What I find most interesting in the specific genetic support for Rett is, this is just how Anavex perceives helping this indication.
This genetic supercharger is very likely also up-regulating every mitochondrial organ system in the body.
The mouse data suggests these other indications by way of the Patent. And Anavex didn't even mention the blood pressure improvement, sinus rhythm or ocular benefits.
The other thing is, Blarcamesine is encouraging the bodies own mechanisms to accomplish this. This isn't some Lab junkie floating another trial and error gene splice.
News 
Market Data 
Discover 
AI
